Phase III, International, Randomized, Controlled Study of Rigosertib versus Physician’s choice of Treatment in Patients with Myelodysplastic Syndrome after Failure of a Hypomethylating Agent

Type of Cancer
Myelodysplastic Syndrome

Phase

Division (Location)

Study ID

NCT#

Brief Description
Phase III, International, Randomized, Controlled Study of Rigosertib versus Physician’s choice of Treatment in Patients with Myelodysplastic Syndrome after Failure of a Hypomethylating Agent

To find out more about this clinical trial, or to schedule an appointment, call (201) 518-3587.